Search Results 311-320 of 18055 for progesterone

  1. Clinical trials - Oncology (Medical)

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  2. Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery - Mayo Clinic

    Intrauterine device (non-progesterone T); Vaginal sponge (containing spermicide). Other acceptable forms: 100% commitment to abstinence. Unacceptable forms of ...

  3. Conjugated estrogens synthetic a (oral route) - Side effects & dosage - Mayo Clinic

    It is also used to treat moderate to severe changes in and around the vagina (eg, vaginal dryness, itching, and burning) caused by menopause. This medicine is ...

  4. Estrogen receptor mRNA directed therapy for triple negative breast cancer

    progesterone receptor, and HER2/neu receptor. Most TNBCs manifest as high grade invasive ductal carcinomas, of which 70-80% display a basal-like pattern of.

  5. Clinical trials - Oncology (Medical)

    ... progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable ...

  6. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

    Note: Use of oral (estrogen and progesterone), injected or implanted hormonal methods of contraception or intrauterine system (IUS) or any other form of ...

  7. Publications - Savanna Tierney, Ph.D., L.P. - Mayo Clinic

    ... progesterone receptor expression in female rats. Horm Behav. 2017 Nov; 96:31-41 Epub 2017 Sept 18. View PubMed; Tierney SM, Sheppard DP, Kordovski VM, Faytell ...

  8. A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer - Mayo Clinic

    Known hormone receptor status (estrogen receptor and progesterone receptor); Baseline LVEF ≥ 55%; Women of childbearing potential and male participants with ...

  9. A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer - Mayo Clinic

    ... progesterone only). Women of child bearing potential (WOCBP) must have a negative serum or urine pregnancy test within 5 days prior to randomization. The ...

  10. Letrozole After Tamoxifen in Treating Women With Breast Cancer - Mayo Clinic

    Estrogen or progesterone receptor positive as defined by tumor receptor content at least 10 fmol/mg protein or receptor positive by ERICA or PgRICA; Unknown ...